Sanjay Nayak

Insider Reports History

Location
Bedford, MA
Signature
/s/ Todd Anderman, Attorney-in-Fact for Sanjay Nayak
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sanjay Nayak:

Company Role Class Num Shares Value Price $ Report Date Ownership
OCULAR THERAPEUTIX, INC Chief Strategy Officer Common Stock 342,760 $3,734,301 $10.89 02 Jan 2026 Direct
OCULAR THERAPEUTIX, INC Chief Strategy Officer Stock Option (Right to Buy) 197,650 02 Jan 2026 Direct

Insider Reports Filed by Sanjay Nayak

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OCUL OCULAR THERAPEUTIX, INC 02 Jan 2026 2 $0 4 Chief Strategy Officer 06 Jan 2026, 16:06
OCUL OCULAR THERAPEUTIX, INC 24 Nov 2025 1 -$22,611 4 Chief Strategy Officer 26 Nov 2025, 16:02
OCUL OCULAR THERAPEUTIX, INC 25 Aug 2025 1 -$22,695 4 Chief Strategy Officer 27 Aug 2025, 18:43
OCUL OCULAR THERAPEUTIX, INC 23 May 2025 1 -$13,351 4 Chief Strategy Officer 27 May 2025, 17:42
OCUL OCULAR THERAPEUTIX, INC 24 Feb 2025 1 -$12,962 4 Chief Strategy Officer 26 Feb 2025, 18:22
OCUL OCULAR THERAPEUTIX, INC 11 Feb 2025 2 $0 4 Chief Strategy Officer 13 Feb 2025, 20:35
OCUL OCULAR THERAPEUTIX, INC 25 Nov 2024 1 -$16,326 4 Chief Strategy Officer 27 Nov 2024, 07:49
OCUL OCULAR THERAPEUTIX, INC 23 Aug 2024 1 -$16,525 4 Chief Strategy Officer 27 Aug 2024, 17:19
OCUL OCULAR THERAPEUTIX, INC 23 May 2024 1 -$13,280 4 Chief Strategy Officer 28 May 2024, 17:01
OCUL OCULAR THERAPEUTIX, INC 22 Feb 2024 2 $0 4 Chief Strategy Officer 26 Feb 2024, 20:06
OCUL OCULAR THERAPEUTIX, INC 21 Feb 2024 0 $0 3 Chief Strategy Officer 26 Feb 2024, 20:02